April 8, 2019 Price forecast | 2 weeks: 6.57% | 1 month: 7.33% | 3 months: 10.58% | Premium Forecast


AVEO stock forecast

Our latest prediction for AVEO Pharmaceuticals, Inc.'s stock price was made on the April 8, 2019 when the stock price was at 1.10$.

In the short term (2weeks), AVEO's stock price should outperform the market by 6.57%. During that period the price should oscillate between -11.83% and +38.19%.

In the medium term (3months), AVEO's stock price should outperform the market by 10.58%. During that period the price should oscillate between -23.48% and +92.77%.


About AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

At the moment the company generates 30M USD in revenues.

On its last earning announcement, the company reported a profit of 0.13$ per share.

The book value per share is -0.38$

AVEO Pharmaceuticals, Inc. website


Three months stock forecastApril 8, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
30M 100.00% - -0.30% 36M 0.13 - - 155M -0.38 -2M - -2M